I like your thinking Mozzarc. It will be interesting to see if there is a discernible reaction tomorrow.
I live in Perth and would love to attend, BUT I'm in the Gold Coast on business... Bad luck eh !
I've been researching PAR lately and have dipped a toe in the water. What I'm trying to understand is on 15/4/19 PAR announced that they met their SECONDARY endpoints for the OA Knee trial... but what about the primary endpoint(s) ? They don't seem to have addressed this directly. Is there more information on the primary endpoints still to be released ?
I do like the fact that Paul Rennie bought an additional $49k on-market after this release.
Apologies if this has already been discussed.
research reports and media, page-34
-
- There are more pages in this discussion • 4,284 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25008 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 34768 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |